Thank you very much for your interest to Mircludex B.
You probably know that the drug was developed by the German scientists and phase 1 clinical trial in healthy people has finished in Germany early this year.
Now we are preparing for the next stage of clinical trial to show the drug effect in patients suffering from CHB (without CHD). This will be the first trial in patients. Several hepatology clinics in Russia will participate in. We expect to have the result on the second half next year. Based on it we will correct further development program.
Recent update for clinical trial published on 21Sept2012.
The company "Gepatera" Health Ministry received permission to conduct clinical trials
This was written in Russia.
he company "Gepatera" Health Ministry received permission to conduct clinical trials
September 21, 2012
This site complies with the HONcode standard for trustworthy health information.
The Content on this Site is presented in a summary fashion, and is intended to be used for educational and entertainment purposes only. It is not intended to be and should not be interpreted as medical advice or a diagnosis of any health or fitness problem, condition or disease; or a recommendation for a specific test, doctor, care provider, procedure, treatment plan, product, or course of action. Med Help International, Inc. is not a medical or healthcare provider and your use of this Site does not create a doctor / patient relationship. We disclaim all responsibility for the professional qualifications and licensing of, and services provided by, any physician or other health providers posting on or otherwise referred to on this Site and/or any Third Party Site. Never disregard the medical advice of your physician or health professional, or delay in seeking such advice, because of something you read on this Site. We offer this Site AS IS and without any warranties. By using this Site you agree to the following Terms and Conditions. If you think you may have a medical emergency, call your physician or 911 immediately.